Yale researchers find genes behind aggressive endometrial cancer
Yale and Yale Cancer Center researchers have defined the genetic landscape of uterine serous carcinoma (USC) tumors, a chemo-resistant, aggressive form of endometrial cancer, findings that point to new treatment opportunities. The collaborative team—which included researchers with expertise in gynecological cancer, genomics, and computational biology— identified a number of new genes that are frequently mutated in USC.
Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.